Issued Vaccine Lots

FDA Lot-Release Authorizations

These memos show the authority for the manufacturer to release anthrax vaccine from the manufacturing plant. Each lot of every vaccine produced in the United States must be individually released in this way, after having been tested for sterility, purity, potency, and general safety. Lot-release tests are performed by the manufacturer and audited by FDA. View Pre-Renovation Lots
select
FAV111 PDF 17 Mar 05
FAV114 PDF 17 Mar 05